Araştırma Makalesi
BibTex RIS Kaynak Göster

YENİ OKSAZOLİDİNONLARIN ANTİMİKROBİYAL AKTİVİTELERİNİ DEĞERLENDİREN BİR ARAŞTIRMA

Yıl 2018, Cilt: 42 Sayı: 3, 32 - 37, 30.09.2018

Öz

Amaç: Bu çalışmada, bazı yeni oksazolidinon türevlerinin antimikrobiyal etkileri S. aureus ATCC 25923, E. coli ATCC 25922, B. subtilis ATCC 6633, metisilin-dirençli Staphylococcus aureus (MRSA) klinik izolatı ve C. albicans ATCC 10231’e karşı incelenmiştir.

Gereç ve Yöntem: Daha önce elde edilen ve yayınlanan 10 oksazolidinonların antimikrobiyal aktivitesi test edilmiştir ve çalışma Mueller-Hinton broth ve Sabouraud dekstroz broth içinde gerçekleştirilmiştir.

Sonuç ve Tartışma: E5 ve E9 bileşikleri, sırasıyla, 25 μg/mL ve 50 μg/mL ile hem bakteri hem de mantarlara karşı antimikrobiyal aktivite göstermiştir. Bizim bu araştırmamız ve diğer bazı çalışmalar, elektro-negatiflik derecesinin biyolojik aktivite için çok önemli olduğunu göstermiştir.

Kaynakça

  • Das, B., Rajarao, AVS., Sonalı, R., Yadav, A., Ray, A., Pandya, M., Rattan, A., Mehta, A. (2009). Synthesis and biological activity of novel oxazolidinones. Bioorganical and Medicinal Chemistry Letters, 19, 6424-6428.
  • Desai, K.R., Mistry, R.N. (2005). Studies on Synthesis of Some Novel Heterocyclic Azlactone Derivatives and Imidazolinone Derivatives and their Antimicrobial Activity. E-Journal Chemistry, 2, 42-51.
  • El-Gohary, N.S., Shaaban, M.I. (2017). Synthesis, antimicrobial, antiquorum-sensing and antitumor activities of new benzimidazole analogs. European Journal of Medicinal Chemistry, 137, 439-449.
  • Zhu, M., Gokhale, V.M., Szabo, L., Munoz, R.M., Baek, H., Bashyam, S., Hurley, L.H., Von Hoff, D.D., Han, H. (2007). Identification of a novel inhibitor of urokinase-type plasminogen activator. Molecular Cancer Theraphy, 6, 1348-1356.
  • Kuzikov, A.V., Dugin, N.O., Stulov, S.V., Shcherbinin, D.S., Zharkova, M.S., Tkachev, Y.V.,Timofeev, V.P., Veselovsky, A.V., Shumyantseva, V.V., Misharin, A.Y. (2014) Novel oxazolinyl derivatives of pregna- 5,17(20)-diene as 17α-hydroxylase/17,20-lyase (CYP17A1) inhibitors. Steroids, 88, 66-71.
  • Diacon, A.H., Groote-Bidlingmanier, F., Donald, P.R. (2014). A new 6-nitro-2,3-dihydroimidazo-[2,1-b]oxazole for the management of tuberculosis resistant to at least isoniazid and rifampisin. Expert Opinion on Orphan Drugs, 2, 87-94.
  • Garg, P., Chaudhary, S., Milton, M.D. (2014) Synthesis of 2-Aryl/Heteroaryloxazolines from Nitriles under Metal and Catalyst-Free Conditions and Evaluation of Their Antioxidant Activities. Journal of Organic Chemistry, 79, 8668−8677.
  • Temiz-Arpaci, O., Coban, T., Tekiner-Gulbas, B., Can-Eke, B., Yildiz, I., Aki-Sener, E., Yalcin, I., Iscan, M.A. (2006). Study on the antioxidant activities of some new benzazole derivatives. Acta Biologica Hungarica, 57, 201-209.
  • Mariappan, G., Saha, B.P., Datta, S., Kumar, D., Haldar, P.K. (2011) Design, synthesis and antidiabetic evaluation of oxazolone derivatives. Journal of Chemical Science, 123, 335-334.
  • Brickner, S.J., Hutchinson, D.K., Barbachyn, M.R., Manninen, P.R., Ulanowicz, D.A., Garmon, K.C., Hendges, S.K., Toops, D.S., Ford, C.W., Zurenko, G.E. (1996). Synthesis and Antibacterial Activity of U-100592 and U-100766, Two Oxazolidinone Antibacterial Agents for the Potential Treatment of Multidrug-Resistant Gram-Positive Bacterial Infections. Journal of Medicinal Chemistry, 39, 673-679.
  • Kuş, C., Uğurlu, E., Özdamar, E.D., Can-Eke, B. (2017). Synthesis and Antioxidant Properties of New Oxazole-5(4H)-one Derivatives. Turkish Journal of Pharmaceutical Sciences, 14(2), 174-178.
  • NCCLS. (2000). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, 5th ed. NCCLS document. M7-A5. NCCLS.
  • Wayne, P.A. (2012). CLSI. Methods For Dilution Antimicrobial Susceptibility Tests For Bacteria That Grow Aerobically; Approved Standard 9 Th Edition. CLSI Document M07-A9: Clinical and Laboratory Standards Institute.
  • Wayne, P.A. (2015). Performance Standards For Antimicrobial Disk Susceptibility Tests; Approved Standard 12th Edition, CLSI Document, M02, A12.

A RESEARCH FOR SOME OXAZOLIDINONES TO EVALUATE THEIR ANTIMICROBIAL ACTIVITY

Yıl 2018, Cilt: 42 Sayı: 3, 32 - 37, 30.09.2018

Öz

Objectives: In this research, antimicrobial activity of some new oxazolidinone derivatives were evaluated against S. aureus ATCC 25923, E. coli ATCC 25922, B. subtilis ATCC 6633, methicillin-resistant Staphylococcus aureus (MRSA) clinical isolate and C. albicans ATCC 10231.

Material and Method: Formerly obtained and published 10 oxazolidinones were tested against antimicrobial activity and this evaluation was carried out in Mueller-Hinton broth and Sabouraud dextrose broth.

Result and Discussion: Compounds E5, and E9 showed antimicrobial activity against both bacteria and fungi with 25 μg/mL and 50 μg/mL, respectively. Our present research and the others have shown that the electro-negativity degree is very important for the biological activity.

Kaynakça

  • Das, B., Rajarao, AVS., Sonalı, R., Yadav, A., Ray, A., Pandya, M., Rattan, A., Mehta, A. (2009). Synthesis and biological activity of novel oxazolidinones. Bioorganical and Medicinal Chemistry Letters, 19, 6424-6428.
  • Desai, K.R., Mistry, R.N. (2005). Studies on Synthesis of Some Novel Heterocyclic Azlactone Derivatives and Imidazolinone Derivatives and their Antimicrobial Activity. E-Journal Chemistry, 2, 42-51.
  • El-Gohary, N.S., Shaaban, M.I. (2017). Synthesis, antimicrobial, antiquorum-sensing and antitumor activities of new benzimidazole analogs. European Journal of Medicinal Chemistry, 137, 439-449.
  • Zhu, M., Gokhale, V.M., Szabo, L., Munoz, R.M., Baek, H., Bashyam, S., Hurley, L.H., Von Hoff, D.D., Han, H. (2007). Identification of a novel inhibitor of urokinase-type plasminogen activator. Molecular Cancer Theraphy, 6, 1348-1356.
  • Kuzikov, A.V., Dugin, N.O., Stulov, S.V., Shcherbinin, D.S., Zharkova, M.S., Tkachev, Y.V.,Timofeev, V.P., Veselovsky, A.V., Shumyantseva, V.V., Misharin, A.Y. (2014) Novel oxazolinyl derivatives of pregna- 5,17(20)-diene as 17α-hydroxylase/17,20-lyase (CYP17A1) inhibitors. Steroids, 88, 66-71.
  • Diacon, A.H., Groote-Bidlingmanier, F., Donald, P.R. (2014). A new 6-nitro-2,3-dihydroimidazo-[2,1-b]oxazole for the management of tuberculosis resistant to at least isoniazid and rifampisin. Expert Opinion on Orphan Drugs, 2, 87-94.
  • Garg, P., Chaudhary, S., Milton, M.D. (2014) Synthesis of 2-Aryl/Heteroaryloxazolines from Nitriles under Metal and Catalyst-Free Conditions and Evaluation of Their Antioxidant Activities. Journal of Organic Chemistry, 79, 8668−8677.
  • Temiz-Arpaci, O., Coban, T., Tekiner-Gulbas, B., Can-Eke, B., Yildiz, I., Aki-Sener, E., Yalcin, I., Iscan, M.A. (2006). Study on the antioxidant activities of some new benzazole derivatives. Acta Biologica Hungarica, 57, 201-209.
  • Mariappan, G., Saha, B.P., Datta, S., Kumar, D., Haldar, P.K. (2011) Design, synthesis and antidiabetic evaluation of oxazolone derivatives. Journal of Chemical Science, 123, 335-334.
  • Brickner, S.J., Hutchinson, D.K., Barbachyn, M.R., Manninen, P.R., Ulanowicz, D.A., Garmon, K.C., Hendges, S.K., Toops, D.S., Ford, C.W., Zurenko, G.E. (1996). Synthesis and Antibacterial Activity of U-100592 and U-100766, Two Oxazolidinone Antibacterial Agents for the Potential Treatment of Multidrug-Resistant Gram-Positive Bacterial Infections. Journal of Medicinal Chemistry, 39, 673-679.
  • Kuş, C., Uğurlu, E., Özdamar, E.D., Can-Eke, B. (2017). Synthesis and Antioxidant Properties of New Oxazole-5(4H)-one Derivatives. Turkish Journal of Pharmaceutical Sciences, 14(2), 174-178.
  • NCCLS. (2000). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, 5th ed. NCCLS document. M7-A5. NCCLS.
  • Wayne, P.A. (2012). CLSI. Methods For Dilution Antimicrobial Susceptibility Tests For Bacteria That Grow Aerobically; Approved Standard 9 Th Edition. CLSI Document M07-A9: Clinical and Laboratory Standards Institute.
  • Wayne, P.A. (2015). Performance Standards For Antimicrobial Disk Susceptibility Tests; Approved Standard 12th Edition, CLSI Document, M02, A12.
Toplam 14 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Bölüm Araştırma Makalesi
Yazarlar

Canan Kus

Ezgi Ugurlu Bu kişi benim

Nurten Altanlar Bu kişi benim

Yayımlanma Tarihi 30 Eylül 2018
Gönderilme Tarihi 29 Ağustos 2018
Yayımlandığı Sayı Yıl 2018 Cilt: 42 Sayı: 3

Kaynak Göster

APA Kus, C., Ugurlu, E., & Altanlar, N. (2018). A RESEARCH FOR SOME OXAZOLIDINONES TO EVALUATE THEIR ANTIMICROBIAL ACTIVITY. Journal of Faculty of Pharmacy of Ankara University, 42(3), 32-37.
AMA Kus C, Ugurlu E, Altanlar N. A RESEARCH FOR SOME OXAZOLIDINONES TO EVALUATE THEIR ANTIMICROBIAL ACTIVITY. Ankara Ecz. Fak. Derg. Eylül 2018;42(3):32-37.
Chicago Kus, Canan, Ezgi Ugurlu, ve Nurten Altanlar. “A RESEARCH FOR SOME OXAZOLIDINONES TO EVALUATE THEIR ANTIMICROBIAL ACTIVITY”. Journal of Faculty of Pharmacy of Ankara University 42, sy. 3 (Eylül 2018): 32-37.
EndNote Kus C, Ugurlu E, Altanlar N (01 Eylül 2018) A RESEARCH FOR SOME OXAZOLIDINONES TO EVALUATE THEIR ANTIMICROBIAL ACTIVITY. Journal of Faculty of Pharmacy of Ankara University 42 3 32–37.
IEEE C. Kus, E. Ugurlu, ve N. Altanlar, “A RESEARCH FOR SOME OXAZOLIDINONES TO EVALUATE THEIR ANTIMICROBIAL ACTIVITY”, Ankara Ecz. Fak. Derg., c. 42, sy. 3, ss. 32–37, 2018.
ISNAD Kus, Canan vd. “A RESEARCH FOR SOME OXAZOLIDINONES TO EVALUATE THEIR ANTIMICROBIAL ACTIVITY”. Journal of Faculty of Pharmacy of Ankara University 42/3 (Eylül 2018), 32-37.
JAMA Kus C, Ugurlu E, Altanlar N. A RESEARCH FOR SOME OXAZOLIDINONES TO EVALUATE THEIR ANTIMICROBIAL ACTIVITY. Ankara Ecz. Fak. Derg. 2018;42:32–37.
MLA Kus, Canan vd. “A RESEARCH FOR SOME OXAZOLIDINONES TO EVALUATE THEIR ANTIMICROBIAL ACTIVITY”. Journal of Faculty of Pharmacy of Ankara University, c. 42, sy. 3, 2018, ss. 32-37.
Vancouver Kus C, Ugurlu E, Altanlar N. A RESEARCH FOR SOME OXAZOLIDINONES TO EVALUATE THEIR ANTIMICROBIAL ACTIVITY. Ankara Ecz. Fak. Derg. 2018;42(3):32-7.

Kapsam ve Amaç

Ankara Üniversitesi Eczacılık Fakültesi Dergisi, açık erişim, hakemli bir dergi olup Türkçe veya İngilizce olarak farmasötik bilimler alanındaki önemli gelişmeleri içeren orijinal araştırmalar, derlemeler ve kısa bildiriler için uluslararası bir yayım ortamıdır. Bilimsel toplantılarda sunulan bildiriler supleman özel sayısı olarak dergide yayımlanabilir. Ayrıca, tüm farmasötik alandaki gelecek ve önceki ulusal ve uluslararası bilimsel toplantılar ile sosyal aktiviteleri içerir.